These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

923 related items for PubMed ID: 26121380

  • 1. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
    Yamamoto T, Wolf HG, Sinzobahamvya N, Asfour B, Hraska V, Schindler E.
    Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
    [Abstract] [Full Text] [Related]

  • 2. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M, Velik-Salchner C, Stalzer B, Margreiter J, Klingler A, Streif W, Fries D, Innerhofer P.
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [Abstract] [Full Text] [Related]

  • 3. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB, Veerhoek D, van den Brom CE, van Barneveld LJ, Boer C.
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
    [Abstract] [Full Text] [Related]

  • 4. Heparin-protamine balance after neonatal cardiopulmonary bypass surgery.
    Peterson JA, Maroney SA, Zwifelhofer W, Wood JP, Yan K, Bercovitz RS, Woods RK, Mast AE.
    J Thromb Haemost; 2018 Oct; 16(10):1973-1983. PubMed ID: 30016577
    [Abstract] [Full Text] [Related]

  • 5. Heparin Reversal After Cardiopulmonary Bypass: Are Point-of-Care Coagulation Tests Interchangeable?
    Willems A, Savan V, Faraoni D, De Ville A, Rozen L, Demulder A, Van der Linden P.
    J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1184-9. PubMed ID: 27461795
    [Abstract] [Full Text] [Related]

  • 6. Automated protamine dose assay in heparin reversal management after cardiopulmonary by pass.
    Guarracino F, De Cosmo D, Penzo D, Tedesco M, Bossi A, Zussa C, Polesel E, De Stefani R.
    Minerva Anestesiol; 2001 Apr; 67(4):165-9. PubMed ID: 11376504
    [Abstract] [Full Text] [Related]

  • 7. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ, Joist JH, Hogue CW, Alsoufiev A, Kater K, Goodnough LT, Santoro SA, Spitznagel E, Rosenblum M, Lappas DG.
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [Abstract] [Full Text] [Related]

  • 8. Are the point-of-care diagnostics MULTIPLATE and ROTEM valid in the setting of high concentrations of heparin and its reversal with protamine?
    Gertler R, Wiesner G, Tassani-Prell P, Braun SL, Martin K.
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):981-6. PubMed ID: 21315618
    [Abstract] [Full Text] [Related]

  • 9. Impact of protamine dose on activated clotting time and thromboelastography in infants and small children undergoing cardiopulmonary bypass.
    Gautam NK, Schmitz ML, Harrison D, Zabala LM, Killebrew P, Belcher RH, Prodhan P, McKamie W, Norvell DC.
    Paediatr Anaesth; 2013 Mar; 23(3):233-41. PubMed ID: 23279140
    [Abstract] [Full Text] [Related]

  • 10. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
    Meesters MI, Veerhoek D, de Lange F, de Vries JW, de Jong JR, Romijn JW, Kelchtermans H, Huskens D, van der Steeg R, Thomas PW, Burtman DT, van Barneveld LJ, Vonk AB, Boer C.
    Thromb Haemost; 2016 Aug 01; 116(2):251-61. PubMed ID: 27277211
    [Abstract] [Full Text] [Related]

  • 11. [Heparin monitoring during cardiopulmonary bypass in congenital heart surgery].
    Isomatsu Y, Imai Y, Seo K, Terada M, Aoki M, Shin'oka T.
    Kyobu Geka; 2000 Nov 01; 53(12):1001-4. PubMed ID: 11079303
    [Abstract] [Full Text] [Related]

  • 12. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass.
    Levin AI, Heine AM, Coetzee JF, Coetzee A.
    J Cardiothorac Vasc Anesth; 2014 Apr 01; 28(2):224-9. PubMed ID: 24461364
    [Abstract] [Full Text] [Related]

  • 13. Validation of rotational thromboelastometry during cardiopulmonary bypass: A prospective, observational in-vivo study.
    Gronchi F, Perret A, Ferrari E, Marcucci CM, Flèche J, Crosset M, Schoettker P, Marcucci C.
    Eur J Anaesthesiol; 2014 Feb 01; 31(2):68-75. PubMed ID: 23867776
    [Abstract] [Full Text] [Related]

  • 14. Early thromboelastometric variables reliably predict maximum clot firmness in patients undergoing cardiac surgery: a step towards earlier decision making.
    Dirkmann D, Görlinger K, Dusse F, Kottenberg E, Peters J.
    Acta Anaesthesiol Scand; 2013 May 01; 57(5):594-603. PubMed ID: 23240733
    [Abstract] [Full Text] [Related]

  • 15. Optimal protamine dosing after cardiopulmonary bypass: The PRODOSE adaptive randomised controlled trial.
    Miles LF, Burt C, Arrowsmith J, McKie MA, Villar SS, Govender P, Shaylor R, Tan Z, De Silva R, Falter F.
    PLoS Med; 2021 Jun 01; 18(6):e1003658. PubMed ID: 34097705
    [Abstract] [Full Text] [Related]

  • 16. Is 300 Seconds ACT Safe and Efficient during MiECC Procedures?
    Bauer A, Hausmann H, Schaarschmidt J, Szlapka M, Scharpenberg M, Eberle T, Hasenkam JM.
    Thorac Cardiovasc Surg; 2019 Apr 01; 67(3):191-202. PubMed ID: 29290078
    [Abstract] [Full Text] [Related]

  • 17. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
    Guzzetta NA, Monitz HG, Fernandez JD, Fazlollah TM, Knezevic A, Miller BE.
    Anesth Analg; 2010 Jul 01; 111(1):173-9. PubMed ID: 20519414
    [Abstract] [Full Text] [Related]

  • 18. The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph.
    Khan NU, Wayne CK, Barker J, Strang T.
    Eur J Anaesthesiol; 2010 Jul 01; 27(7):624-7. PubMed ID: 20485179
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
    Tao W, Deyo DJ, Brunston RL, Vertrees RA, Grochoske TL, Zwischenberger JB.
    ASAIO J; 1997 Jul 01; 43(5):M825-30. PubMed ID: 9360162
    [Abstract] [Full Text] [Related]

  • 20. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
    Esposito RA, Culliford AT, Colvin SB, Thomas SJ, Lackner H, Spencer FC.
    J Thorac Cardiovasc Surg; 1983 Feb 01; 85(2):174-85. PubMed ID: 6823136
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.